Hamilton Lane Advisors LLC Decreases Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Hamilton Lane Advisors LLC cut its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 14.9% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 21,605 shares of the health services provider’s stock after selling 3,768 shares during the quarter. Teladoc Health makes up about 0.5% of Hamilton Lane Advisors LLC’s investment portfolio, making the stock its 26th largest position. Hamilton Lane Advisors LLC’s holdings in Teladoc Health were worth $2,740,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Pinnacle Bancorp Inc. boosted its position in shares of Teladoc Health by 78.3% in the 3rd quarter. Pinnacle Bancorp Inc. now owns 205 shares of the health services provider’s stock worth $26,000 after buying an additional 90 shares in the last quarter. Princeton Global Asset Management LLC purchased a new position in Teladoc Health in the 2nd quarter valued at about $30,000. Psagot Investment House Ltd. purchased a new position in Teladoc Health in the 2nd quarter valued at about $30,000. Gables Capital Management Inc. purchased a new position in Teladoc Health in the 2nd quarter valued at about $33,000. Finally, PARK CIRCLE Co purchased a new position in Teladoc Health in the 2nd quarter valued at about $33,000. Institutional investors and hedge funds own 80.67% of the company’s stock.

In other news, insider Arnnon Geshuri sold 523 shares of the stock in a transaction that occurred on Monday, November 1st. The stock was sold at an average price of $150.66, for a total transaction of $78,795.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Sandra L. Fenwick sold 3,587 shares of the stock in a transaction that occurred on Thursday, October 14th. The shares were sold at an average price of $140.00, for a total value of $502,180.00. The disclosure for this sale can be found here. Insiders sold 19,219 shares of company stock valued at $2,802,376 in the last ninety days. 6.47% of the stock is owned by corporate insiders.

A number of research analysts have issued reports on TDOC shares. Cantor Fitzgerald reduced their target price on shares of Teladoc Health from $185.00 to $150.00 and set a “neutral” rating on the stock in a report on Thursday, October 28th. Wells Fargo & Company upped their target price on shares of Teladoc Health from $156.00 to $165.00 and gave the company an “overweight” rating in a report on Friday, October 29th. Argus lowered shares of Teladoc Health from a “buy” rating to a “hold” rating in a report on Monday, August 2nd. Stifel Nicolaus reduced their target price on shares of Teladoc Health from $153.00 to $135.00 and set a “hold” rating on the stock in a report on Monday. Finally, Barclays reduced their target price on shares of Teladoc Health from $170.00 to $150.00 and set an “equal weight” rating on the stock in a report on Thursday, October 28th. Fifteen equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $181.56.

TDOC traded up $2.77 on Thursday, reaching $106.00. 6,284,653 shares of the company’s stock were exchanged, compared to its average volume of 3,046,038. The company has a debt-to-equity ratio of 0.08, a quick ratio of 3.64 and a current ratio of 3.83. Teladoc Health, Inc. has a twelve month low of $100.51 and a twelve month high of $308.00. The company’s 50 day moving average is $134.87 and its 200-day moving average is $144.15. The company has a market cap of $16.97 billion, a price-to-earnings ratio of -18.37 and a beta of 0.33.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, October 27th. The health services provider reported ($0.53) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.70) by $0.17. Teladoc Health had a negative net margin of 43.60% and a negative return on equity of 1.47%. The company had revenue of $521.70 million during the quarter, compared to the consensus estimate of $516.79 million. During the same quarter last year, the company earned ($0.13) earnings per share. Teladoc Health’s revenue for the quarter was up 80.6% on a year-over-year basis. Sell-side analysts forecast that Teladoc Health, Inc. will post -3.2 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Read More: What defines an oversold asset?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.